Cargando…

Correlates of Treatment Patterns Among Youth With Type 2 Diabetes

OBJECTIVE: To describe treatment regimens in youth with type 2 diabetes and examine associations between regimens, demographic and clinical characteristics, and glycemic control. RESEARCH DESIGN AND METHODS: This report includes 474 youth with a clinical diagnosis of type 2 diabetes who completed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Badaru, Angela, Klingensmith, Georgeanna J., Dabelea, Dana, Mayer-Davis, Elizabeth J., Dolan, Lawrence, Lawrence, Jean M., Marcovina, Santica, Beavers, Daniel, Rodriguez, Beatriz L., Imperatore, Giuseppina, Pihoker, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867996/
https://www.ncbi.nlm.nih.gov/pubmed/24026554
http://dx.doi.org/10.2337/dc13-1124
_version_ 1782296392434188288
author Badaru, Angela
Klingensmith, Georgeanna J.
Dabelea, Dana
Mayer-Davis, Elizabeth J.
Dolan, Lawrence
Lawrence, Jean M.
Marcovina, Santica
Beavers, Daniel
Rodriguez, Beatriz L.
Imperatore, Giuseppina
Pihoker, Catherine
author_facet Badaru, Angela
Klingensmith, Georgeanna J.
Dabelea, Dana
Mayer-Davis, Elizabeth J.
Dolan, Lawrence
Lawrence, Jean M.
Marcovina, Santica
Beavers, Daniel
Rodriguez, Beatriz L.
Imperatore, Giuseppina
Pihoker, Catherine
author_sort Badaru, Angela
collection PubMed
description OBJECTIVE: To describe treatment regimens in youth with type 2 diabetes and examine associations between regimens, demographic and clinical characteristics, and glycemic control. RESEARCH DESIGN AND METHODS: This report includes 474 youth with a clinical diagnosis of type 2 diabetes who completed a SEARCH for Diabetes in Youth study visit. Diabetes treatment regimen was categorized as lifestyle alone, metformin monotherapy, any oral hypoglycemic agent (OHA) other than metformin or two or more OHAs, insulin monotherapy, and insulin plus any OHA(s). Association of treatment with demographic and clinical characteristics (fasting C-peptide [FCP], diabetes duration, and self-monitoring of blood glucose [SMBG]), and A1C was assessed by χ(2) and ANOVA. Multiple linear regression models were used to evaluate independent associations of treatment regimens and A1C, adjusting for demographics, diabetes duration, FCP, and SMBG. RESULTS: Over 50% of participants reported treatment with metformin alone or lifestyle. Of the autoantibody-negative youth, 40% were on metformin alone, while 33% were on insulin-containing regimens. Participants on metformin alone had a lower A1C (7.0 ± 2.0%, 53 ± 22 mmol/mol) than those on insulin alone (9.2 ± 2.7%, 77 ± 30 mmol/mol) or insulin plus OHA (8.6 ± 2.6%, 70 ± 28 mmol/mol) (P < 0.001). These differences remained significant after adjustment (7.5 ± 0.3%, 58 ± 3 mmol/mol; 9.1 ± 0.4%, 76 ± 4 mmol/mol; and 8.6 ± 0.4%, 70 ± 4 mmol/mol) (P < 0.001) and were more striking in those with diabetes for ≥2 years (7.9 ± 2.8, 9.9 ± 2.8, and 9.8 ± 2.6%). Over one-half of those on insulin-containing therapies still experience treatment failure (A1C ≥8%, 64 mmol/mol). CONCLUSIONS: Approximately half of youth with type 2 diabetes were managed with lifestyle or metformin alone and had better glycemic control than individuals using other therapies. Those with longer diabetes duration in particular commonly experienced treatment failures, and more effective management strategies are needed.
format Online
Article
Text
id pubmed-3867996
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-38679962015-01-01 Correlates of Treatment Patterns Among Youth With Type 2 Diabetes Badaru, Angela Klingensmith, Georgeanna J. Dabelea, Dana Mayer-Davis, Elizabeth J. Dolan, Lawrence Lawrence, Jean M. Marcovina, Santica Beavers, Daniel Rodriguez, Beatriz L. Imperatore, Giuseppina Pihoker, Catherine Diabetes Care Clinical Care/Education/Nutrition/Psychosocial Research OBJECTIVE: To describe treatment regimens in youth with type 2 diabetes and examine associations between regimens, demographic and clinical characteristics, and glycemic control. RESEARCH DESIGN AND METHODS: This report includes 474 youth with a clinical diagnosis of type 2 diabetes who completed a SEARCH for Diabetes in Youth study visit. Diabetes treatment regimen was categorized as lifestyle alone, metformin monotherapy, any oral hypoglycemic agent (OHA) other than metformin or two or more OHAs, insulin monotherapy, and insulin plus any OHA(s). Association of treatment with demographic and clinical characteristics (fasting C-peptide [FCP], diabetes duration, and self-monitoring of blood glucose [SMBG]), and A1C was assessed by χ(2) and ANOVA. Multiple linear regression models were used to evaluate independent associations of treatment regimens and A1C, adjusting for demographics, diabetes duration, FCP, and SMBG. RESULTS: Over 50% of participants reported treatment with metformin alone or lifestyle. Of the autoantibody-negative youth, 40% were on metformin alone, while 33% were on insulin-containing regimens. Participants on metformin alone had a lower A1C (7.0 ± 2.0%, 53 ± 22 mmol/mol) than those on insulin alone (9.2 ± 2.7%, 77 ± 30 mmol/mol) or insulin plus OHA (8.6 ± 2.6%, 70 ± 28 mmol/mol) (P < 0.001). These differences remained significant after adjustment (7.5 ± 0.3%, 58 ± 3 mmol/mol; 9.1 ± 0.4%, 76 ± 4 mmol/mol; and 8.6 ± 0.4%, 70 ± 4 mmol/mol) (P < 0.001) and were more striking in those with diabetes for ≥2 years (7.9 ± 2.8, 9.9 ± 2.8, and 9.8 ± 2.6%). Over one-half of those on insulin-containing therapies still experience treatment failure (A1C ≥8%, 64 mmol/mol). CONCLUSIONS: Approximately half of youth with type 2 diabetes were managed with lifestyle or metformin alone and had better glycemic control than individuals using other therapies. Those with longer diabetes duration in particular commonly experienced treatment failures, and more effective management strategies are needed. American Diabetes Association 2014-01 2013-12-11 /pmc/articles/PMC3867996/ /pubmed/24026554 http://dx.doi.org/10.2337/dc13-1124 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Clinical Care/Education/Nutrition/Psychosocial Research
Badaru, Angela
Klingensmith, Georgeanna J.
Dabelea, Dana
Mayer-Davis, Elizabeth J.
Dolan, Lawrence
Lawrence, Jean M.
Marcovina, Santica
Beavers, Daniel
Rodriguez, Beatriz L.
Imperatore, Giuseppina
Pihoker, Catherine
Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
title Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
title_full Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
title_fullStr Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
title_full_unstemmed Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
title_short Correlates of Treatment Patterns Among Youth With Type 2 Diabetes
title_sort correlates of treatment patterns among youth with type 2 diabetes
topic Clinical Care/Education/Nutrition/Psychosocial Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867996/
https://www.ncbi.nlm.nih.gov/pubmed/24026554
http://dx.doi.org/10.2337/dc13-1124
work_keys_str_mv AT badaruangela correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT klingensmithgeorgeannaj correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT dabeleadana correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT mayerdaviselizabethj correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT dolanlawrence correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT lawrencejeanm correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT marcovinasantica correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT beaversdaniel correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT rodriguezbeatrizl correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT imperatoregiuseppina correlatesoftreatmentpatternsamongyouthwithtype2diabetes
AT pihokercatherine correlatesoftreatmentpatternsamongyouthwithtype2diabetes